New preclinical imaging product line launched by MILabs at the 2014 Annual European Association of Nuclear Medicine Meeting

NewsGuard 100/100 Score

MILabs BV has launched a complete new preclinical product line at the 2014 Annual European Association of Nuclear Medicine Meeting in Gothenburg, Sweden, October 18-22 (www.eanm.org). It consists of the new 4-series comprising U-SPECT4, U-SPECT4CT, VECTor4 and VECTor4CT incorporating significant improvements over the former PLUS-series. The 4-series carries even further the tradition of MILabs to deliver the best SPECT and PET image resolution available in the market.

MILabs

The new systems are more compact and include a dramatically improved X-Ray CT subsystem with reduced radiation dose, increased resolution and speed. The CT subsystem comes at three different resolution levels. The high resolution versions have significant added value for application areas such as. in vivo bone, cancer and arthritis research.

“Our customers are highly enthusiastic about the integrated low dose CT units and we are pleased to offer them dramatically improved resolution as well“, says Frederik Beekman, CEO/CSO of MILabs. This new generation U-SPECT4CT and VECTor4CT brings MILabs even further ahead in terms of combined ultra-high resolution functional and anatomical nuclear imaging. MILabs expects that the next generation U-SPECT4, U-SPECT4CT, VECTor4 and VECTor4CT systems will further accelerate the rapid growth of MILabs’ global customer base.

About MILabs

MILabs provides high-end preclinical imaging solutions for biomedical research. Today these systems contribute worldwide to the development of new diagnostic solutions and therapies for diseases such as diabetes, cancer, cardiac and neurodegenerative diseases. The systems are unique with U-SPECT as the highest resolution, fastest and highest sensitivity small-animal SPECT system and VECTor as the only technology capable of easily acquiring excellent simultaneous SPECT and PET imaging. These MILabs systems can be configured as fully integrated single, dual, or triple modal platform with choice of SPECT, PET and CT, with attractive options to smoothly combine these with Optical or MR imaging subsystems.

For more information please visit: www.milabs.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative diabetes detection method with DiaNet v2, utilizing retinal imaging technology